CClinicalTrials.gg
CompletedNCT04208724Updated Jul 26, 2022

Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization

An interventional study of Training and Cancer Screening intervention in Breast Carcinoma, Cervical Carcinoma and Colorectal Carcinoma, sponsored by Fred Hutchinson Cancer Center. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-26.

Sponsored by Fred Hutchinson Cancer Center · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This pilot trial study uses a structural support program for adoption of cancer screening interventions at a rural community-based organization. Rural communities face unique barriers in implementation of evidence-based interventions due to a lack of infrastructure, community capacity, and expertise as academic and research centers are often clustered in urban areas. The support program may help a rural community-based organization select, adapt, and implement cancer prevention and control evidence-based interventions.

Read the detailed description

OUTLINE:

Community-based organizations participate in the support program, consisting of 2 half-day training workshops over 2 weeks, and 30-minute bi-weekly consultations in order to adapt and implement the cancer screening intervention for community members.

After completion of study, participants are followed up at 3 months.

02

Conditions studied

  • Breast Carcinoma
  • Cervical Carcinoma
  • Colorectal Carcinoma
  • Malignant Solid Neoplasm
03

In context

Carcinoma

6,741 studies on the registry are indexed under Carcinoma; 1,161 are open to participants now.

This study's enrollment of 35 is below the median of 45 across 5,170 interventional studies indexed under Carcinoma.

Browse Carcinoma studies →

Lead sponsor

Fred Hutchinson Cancer Center is the lead sponsor of 537 studies on the registry; 79 are open to participants now.

Of its 57 completed or terminated interventional studies of FDA-regulated products, 45 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Objective II COMMUNITY-BASED ORGANIZATION: Located in the Yakima Valley of Washington State
  • Objective II COMMUNITY-BASED ORGANIZATION: Serve community members who are 18 and older
  • Objective II COMMUNITY-BASED ORGANIZATION: Willing to commit to the 6-month program
  • Objective II PARTICIPANTS: Receiving services from the recruited community-based organization
  • Objective III PARTICIPANTS: Not up-to-date for breast, cervical, and colorectal cancer screening according to current U.S. Preventive Services Tasks Force (USPSTF) guidelines. The current USPSTF recommendations for breast, cervical, and colorectal cancer are:

    • Breast Cancer Screening: Women ages 50-74 should be screened for breast cancer with mammography every 2 years.
    • Cervical Cancer Screening: Women ages 21-29 should be screened for cervical cancer every 3 years with cervical cancer cytology alone. For women ages 30-65, the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years or every 5 years with high risk human papillomavirus (hrHPV) testing in combination of cytology.
    • Colorectal Cancer Screening: Individuals ages 50-75 should be screened for colorectal cancer with guaiac-based fecal occult blood tests (gFOBT) or fecal immunochemical test (FIT) once a year, or colonoscopy every 10 years (USPSTF approves additional screening tests, but these are the most commonly used).
  • Objective III PARTICIPANTS: If the community-based organization selects breast cancer screening, we will recruit women ages 50-74.
  • Objective III PARTICIPANTS: If the community-based organization selects cervical cancer screening, we will recruit women ages 21-65.
  • Objective III PARTICIPANTS: If the community-based organization selects colorectal cancer screening, we will recruit women and men ages 50-75.
  • Objective III PARTICIPANTS: Average risk for breast, cervical, or colorectal cancer
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Training program

    Community-based organizations participate in the support program, consisting of 2 half-day training workshops over 2 weeks, and 30-minute bi-weekly consultations in order to adapt and implement the cancer screening intervention for community members.

    Other: Training · Other: Cancer Screening intervention · Other: Survey Administration

Interventions

  • OtherTraining

    Participate in the training program

    Also known as: Training Programs

  • OtherCancer Screening intervention

    Receive cancer screening intervention

    Also known as: cancer screening

  • OtherSurvey Administration

    Ancillary studies

06

What researchers measure

Primary outcomes

  1. Develop the structural program

    Development of the structural training program and accompanying tools

    Time frame: 3 months

  2. Implementation Monitoring

    Implementation of the evidence-based intervention by the community-based organization including 1) dosage (how many interventions were delivered to the participants), 2) types (for which cancer), 3) length of exposure (for how long), and 4) who is involved in the implementation (by whom).

    Time frame: 4 months

  3. Intention to get screened for cancer (type of cancer will be determined by the community-based organization) pre- and post-intervention

    Difference in the proportion of intention to get screened for cancer pre- and post-intervention using chi-square analyses

    Time frame: Up to 3 months

07

Study locations

1 site
  • Fred Hutch/University of Washington Cancer Consortium
    Seattle, Washington 98109, United States
08

References and documents

Study documents

  • Informed consent form · Jul 22, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04208724
Lead sponsor
Fred Hutchinson Cancer Center
Responsible party
Sponsor
First posted
Dec 23, 2019
Start date
Nov 18, 2020
Primary completion
Jun 30, 2022
Completion
Jun 30, 2022
Last update
Jul 26, 2022

Study contacts

Linda Ko
principal investigator · Fred Hutch/University of Washington Cancer Consortium

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion